Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 26, 2004

 


 

KINDRED HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction

of incorporation or organization)

 

001-14057

(Commission File

Number)

 

61-1323993

(IRS Employer

Identification No.)

 

680 South Fourth Street

Louisville, Kentucky

(Address of principal executive offices)

 

40202-2412

(Zip Code)

 

Registrant’s telephone number, including area code: (502) 596-7300

 

Not Applicable

(Former name or former address, if changed since last report)


Item 5. Other Events and Regulation FD Disclosure.

 

Kindred Healthcare, Inc. (the “Company”) has announced earnings expectations for its continuing operations for fiscal 2004. Revenues for 2004 are expected to approximate between $3.5 billion to $3.6 billion. Operating income, defined as earnings before interest, income taxes, depreciation and rents, is expected to range from $484 million to $494 million. Depreciation and net interest costs for 2004 are expected to approximate $100 million. Net income from continuing operations is expected between $68 million and $75 million, or $1.58 to $1.74 per diluted share (based upon diluted shares of 43 million). For fiscal 2003, the Company reported revenues of $3.3 billion, operating income of $426 million and net income from continuing operations of $49.5 million or $1.41 per diluted share (based upon diluted shares of 35 million).

 

In addition to the risk factors set forth under “Forward Looking Statements,” the Company’s 2004 earnings guidance assumes no significant changes in government reimbursement as well as the successful completion of its previously announced development plans for additional hospitals and institutional pharmacy locations. Fiscal 2004 earnings estimates also assume continued progress in the Company’s transition of its long-term acute care hospitals to the new Medicare prospective payment system and continued stabilization of professional liability costs that are expected to range between $90 million and $100 million in 2004. The Company reported professional liability costs of $90 million in 2003.

 

The Company also announced that the Board of Directors has approved a 2-for-1 stock split in the form of a 100% stock dividend. The new shares will be distributed on May 27, 2004 to stockholders of record at the close of business on May 10, 2004. The earnings guidance set forth above gives effect to the stock split.

 

Forward Looking Statements

 

This Form 8-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

 

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

 

2


Factors that may affect the Company’s plans or results include, without limitation, (a) the Company’s ability to operate pursuant to the terms of its debt obligations and its master lease agreements with Ventas, Inc.; (b) the Company’s ability to meet its rental and debt service obligations; (c) adverse developments with respect to the Company’s results of operations or liquidity; (d) the Company’s ability to attract and retain key executives and other healthcare personnel; (e) increased operating costs due to shortages in qualified nurses and other healthcare personnel; (f) the effects of healthcare reform and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry; (g) changes in the reimbursement rates or methods of payment from third party payors, including the Medicare and Medicaid programs, and changes arising from the Medicare prospective payment system for long-term acute care hospitals and the recently enacted Medicare Prescription Drug, Improvement, and Modernization Act of 2003; (h) national and regional economic conditions, including their effect on the availability and cost of labor, materials and other services; (i) the Company’s ability to control costs, including labor and employee benefit costs; (j) the Company’s ability to comply with the terms of its Corporate Integrity Agreement; (k) the Company’s ability to integrate operations of acquired facilities; (l) the increase in the costs of defending and insuring against alleged professional liability claims and the Company’s ability to predict the estimated costs related to such claims; (m) the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability claims; and (n) the Company’s ability to successfully dispose of unprofitable facilities. Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 

Item 12. Results of Operations and Financial Condition.

 

On April 26, 2004, the Company issued a press release announcing its financial results for the first quarter ended March 31, 2004. The press release, dated April 26, 2004, is attached as Annex A to this Form 8-K. On April 26, 2004, the Company also included the press release on its website at www.kindredhealthcare.com.

 

Annex A is incorporated herein by reference and has been furnished, not filed.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

 

Date: April 27, 2004       By:   /s/    Richard A. Lechleiter
             
               

Richard A. Lechleiter

               

Senior Vice President and Chief Financial Officer

 

3


Annex A

 

[Kindred Logo appears here]

 

Contact: Richard A. Lechleiter

Senior Vice President and

Chief Financial Officer

(502) 596-7734

 

KINDRED HEALTHCARE ANNOUNCES FIRST QUARTER RESULTS

 


 

Company Provides 2004 Earnings Guidance

 

Board of Directors Declares 2-for-1 Stock Split

 

LOUISVILLE, Ky. (April 26, 2004) – Kindred Healthcare, Inc. (the “Company”) (NASDAQ:KIND) today announced its operating results for the first quarter ended March 31, 2004. Share and per share data for all periods presented have been adjusted retroactively to reflect the 2-for-1 stock split discussed in this earnings release.

 

Continuing Operations

 

Revenues for the first quarter of 2004 rose 9% to $871 million compared to $802 million in the year-earlier period. Net income from continuing operations totaled $16.2 million or $0.38 per diluted share compared to $2.5 million or $0.07 per diluted share in the first quarter last year. Operating results for the first quarter of 2004 included pretax income of approximately $2.2 million ($1.3 million net of tax or $0.03 per diluted share) related to the favorable settlement of prior year hospital Medicare cost reports. Operating results for the first quarter of 2003 included pretax charges of approximately $8 million ($5 million net of tax or $0.15 per diluted share) related to changes in estimates of prior year professional liability costs.

 

Kindred President and Chief Executive Officer Paul J. Diaz commented, “We’re continuing to make progress on our goal to deliver more consistent and predictable operating results for our patients, employees and shareholders. In the first quarter, our quality and customer service measures continued to trend favorably. We also reported increased revenues and operating income in each of our four operating divisions compared to the first quarter last year. This success is a reflection of our continuing efforts to improve employee retention, quality and customer service in all of our operations.”

 

As previously announced, the Company began operating Peoplefirst Rehabilitation, a new division in 2004, by combining the Company’s external rehabilitation services operations with the rehabilitation services provided by therapists in Kindred nursing centers. Prior to 2004, the internal rehabilitation services operating results were included in the Company’s nursing center operations. Mr. Diaz commented, “In its first quarter of operations, Peoplefirst Rehabilitation reported revenues of $53 million and operating income of $8.5 million. This new organization is creating a great deal of excitement within the Company around our efforts to improve the quality of care we provide to our residents and external customers. We are confident that this momentum will lead to further external growth in the future.”

 

4


Discontinued Operations

 

Net losses from discontinued operations totaled $2.4 million or $0.06 per diluted share in the first quarter of 2004 compared to net losses of $15.6 million or $0.45 per diluted share in the first quarter of 2003.

 

Earnings Guidance for 2004

 

The Company announced earnings expectations for its continuing operations for fiscal 2004. Revenues for 2004 are expected to approximate between $3.5 billion to $3.6 billion. Operating income, defined as earnings before interest, income taxes, depreciation and rents, is expected to range from $484 million to $494 million. Depreciation and net interest costs for 2004 are expected to approximate $100 million. Net income from continuing operations is expected between $68 million and $75 million, or $1.58 to $1.74 per diluted share (based upon diluted shares of 43 million). For fiscal 2003, the Company reported revenues of $3.3 billion, operating income of $426 million and net income from continuing operations of $49.5 million or $1.41 per diluted share (based upon diluted shares of 35 million).

 

In addition to the risk factors set forth under “Forward Looking Statements,” the Company’s 2004 earnings guidance assumes no significant changes in government reimbursement as well as the successful completion of its previously announced development plans for additional hospitals and institutional pharmacy locations. Fiscal 2004 earnings estimates also assume continued progress in the Company’s transition of its long-term acute care hospitals to the new Medicare prospective payment system and continued stabilization of professional liability costs that are expected to range between $90 million and $100 million in 2004. The Company reported professional liability costs of $90 million in 2003.

 

Mr. Diaz also noted, “The increased stabilization of our operations also has allowed us to return to providing earnings guidance. We believe that the remainder of 2004 offers opportunities to benefit from continued reimbursement visibility, operational improvement in our hospitals and stabilization of professional liability costs in our nursing centers. We also expect our pharmacy and rehabilitation businesses to build on their strong first quarter performance. While several challenges and much work lie ahead, we are optimistic about our 2004 performance.”

 

Stock Split

 

The Company also announced that the Board of Directors has approved a 2-for-1 stock split in the form of a 100% stock dividend. The new shares will be distributed on May 27, 2004 to stockholders of record at the close of business on May 10, 2004.

 

Related to the stock split, Mr. Diaz commented, “We believe that having more shares available from the split announced today will benefit our shareholders by increasing our trading activity and liquidity and reflects the confidence of management and the Board of Directors in our 2004 plan.”

 

Forward Looking Statements

 

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

 

5


Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

 

Factors that may affect the Company’s plans or results include, without limitation, (a) the Company’s ability to operate pursuant to the terms of its debt obligations and its master lease agreements with Ventas, Inc.; (b) the Company’s ability to meet its rental and debt service obligations; (c) adverse developments with respect to the Company’s results of operations or liquidity; (d) the Company’s ability to attract and retain key executives and other healthcare personnel; (e) increased operating costs due to shortages in qualified nurses and other healthcare personnel; (f) the effects of healthcare reform and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry; (g) changes in the reimbursement rates or methods of payment from third party payors, including the Medicare and Medicaid programs, and changes arising from the Medicare prospective payment system for long-term acute care hospitals and the recently enacted Medicare Prescription Drug, Improvement, and Modernization Act of 2003; (h) national and regional economic conditions, including their effect on the availability and cost of labor, materials and other services; (i) the Company’s ability to control costs, including labor and employee benefit costs; (j) the Company’s ability to comply with the terms of its Corporate Integrity Agreement; (k) the Company’s ability to integrate operations of acquired facilities; (l) the increase in the costs of defending and insuring against alleged professional liability claims and the Company’s ability to predict the estimated costs related to such claims; (m) the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability claims; and (n) the Company’s ability to successfully dispose of unprofitable facilities. Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 

Kindred Healthcare, Inc. is a national healthcare services company operating hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business.

 

6


KINDRED HEALTHCARE, INC.

Financial Summary (a)

(Unaudited)

(In thousands, except per share amounts)

 

    

Three months ended

March 31,


 
     2004

    2003

 

Revenues

   $ 871,262     $ 802,158  
    


 


Income from continuing operations

   $ 16,275     $ 2,511  

Loss from discontinued operations, net of income taxes

     (2,435 )     (15,635 )
    


 


Net income (loss)

   $ 13,840     $ (13,124 )
    


 


Earnings (loss) per common share:

                

Basic:

                

Income from continuing operations

   $ 0.46     $ 0.07  

Loss from discontinued operations

     (0.07 )     (0.45 )
    


 


Net income (loss)

   $ 0.39     $ (0.38 )
    


 


Diluted:

                

Income from continuing operations

   $ 0.38     $ 0.07  

Loss from discontinued operations

     (0.06 )     (0.45 )
    


 


Net income (loss)

   $ 0.32     $ (0.38 )
    


 


Shares used in computing earnings (loss)

                

per common share:

                

Basic

     35,414       34,755  

Diluted

     42,721       34,767  

(a) Share and per share data for all periods presented have been adjusted retroactively to reflect a 2-for-1 stock split to be distributed in May 2004.

 

7


KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Operations (a)

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended
March 31,


 
     2004

    2003

 

Revenues

   $ 871,262     $ 802,158  
    


 


Salaries, wages and benefits

     492,071       460,752  

Supplies

     116,733       104,182  

Rent

     64,459       63,078  

Other operating expenses

     145,406       146,839  

Depreciation

     22,046       19,195  

Interest expense

     3,656       2,888  

Investment income

     (1,218 )     (1,635 )
    


 


       843,153       795,299  
    


 


Income from continuing operations before income taxes

     28,109       6,859  

Provision for income taxes

     11,834       4,348  
    


 


Income from continuing operations

     16,275       2,511  

Loss from discontinued operations, net of income taxes

     (2,435 )     (15,635 )
    


 


Net income (loss)

   $ 13,840     $ (13,124 )
    


 


Earnings (loss) per common share:

                

Basic:

                

Income from continuing operations

   $ 0.46     $ 0.07  

Loss from discontinued operations

     (0.07 )     (0.45 )
    


 


Net income (loss)

   $ 0.39     $ (0.38 )
    


 


Diluted:

                

Income from continuing operations

   $ 0.38     $ 0.07  

Loss from discontinued operations

     (0.06 )     (0.45 )
    


 


Net income (loss)

   $ 0.32     $ (0.38 )
    


 


Shares used in computing earnings (loss) per common share:

                

Basic

     35,414       34,755  

Diluted

     42,721       34,767  

 


(a) Share and per share data for all periods presented have been adjusted retroactively to reflect a 2-for-1 stock split to be distributed in May 2004.

 

8


KINDRED HEALTHCARE, INC.

Condensed Consolidated Balance Sheet

(Unaudited)

(In thousands, except per share amounts)

 

     March 31,
2004


    December 31,
2003


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 17,827     $ 66,524  

Cash—restricted

     7,864       7,339  

Insurance subsidiary investments

     175,710       146,325  

Accounts receivable less allowance for loss

     475,238       429,304  

Inventories

     31,135       29,984  

Deferred tax assets

     89,836       89,836  

Assets held for sale

     27,360       27,400  

Other

     54,455       46,375  
    


 


       879,425       843,087  

Property and equipment

     688,959       671,850  

Accumulated depreciation

     (212,963 )     (193,310 )
    


 


       475,996       478,540  

Goodwill

     31,417       31,417  

Insurance subsidiary investments

     66,157       74,618  

Deferred tax assets

     91,991       92,093  

Other

     63,066       65,659  
    


 


     $ 1,608,052     $ 1,585,414  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Accounts payable

   $ 119,057     $ 119,087  

Salaries, wages and other compensation

     207,004       214,113  

Due to third party payors

     27,669       31,406  

Professional liability risks

     71,140       83,725  

Other accrued liabilities

     83,938       88,333  

Income taxes

     46,356       36,684  

Long-term debt due within one year

     4,729       4,532  
    


 


       559,893       577,880  

Long-term debt

     154,708       139,397  

Professional liability risks

     220,714       212,013  

Deferred credits and other liabilities

     58,974       58,559  

Stockholders’ equity (a):

                

Common stock, $0.25 par value; authorized 175,000 shares; issued 36,369 shares – March 31, 2004 and 36,340 shares – December 31, 2003

     9,092       9,085  

Capital in excess of par value

     585,853       585,394  

Deferred compensation

     (6,296 )     (8,040 )

Accumulated other comprehensive income

     496       348  

Retained earnings

     24,618       10,778  
    


 


       613,763       597,565  
    


 


     $ 1,608,052     $ 1,585,414  
    


 


 


(a) Retroactively adjusted to reflect a 2-for-1 stock split to be distributed in May 2004.

 

9


KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Cash Flows

(Unaudited)

(In thousands)

 

     Three months ended
March 31,


 
     2004

    2003

 

Cash flows from operating activities:

                

Net income (loss)

   $ 13,840     $ (13,124 )

Adjustments to reconcile net income (loss) to net cash used in operating activities:

                

Depreciation

     22,046       20,083  

Amortization of deferred compensation costs

     1,743       1,253  

Provision for doubtful accounts

     8,116       6,288  

Other

     (102 )     506  

Change in operating assets and liabilities:

                

Accounts receivable

     (54,304 )     (53,316 )

Inventories and other assets

     (9,468 )     (6,387 )

Accounts payable

     (3,184 )     (2,998 )

Income taxes

     9,912       (5,457 )

Due to third party payors

     (3,737 )     3,551  

Other accrued liabilities

     (9,062 )     27,935  
    


 


Net cash used in operating activities

     (24,200 )     (21,666 )
    


 


Cash flows from investing activities:

                

Purchase of property and equipment

     (17,881 )     (10,565 )

Purchase of insurance subsidiary investments

     (9,776 )     (30,395 )

Sale of insurance subsidiary investments

     5,672       2,333  

Net change in insurance subsidiary cash and cash equivalents

     (16,820 )     (71,911 )

Net change in other investments

     1,777       (4,685 )

Other

     508       (333 )
    


 


Net cash used in investing activities

     (36,520 )     (115,556 )
    


 


Cash flows from financing activities:

                

Net change in revolving credit borrowings

     16,900       —    

Repayment of long-term debt

     (1,032 )     (112 )

Payment of deferred financing costs

     —         (1,596 )

Issuance of common stock

     467       —    

Other

     (4,312 )     (4,967 )
    


 


Net cash provided by (used in) financing activities

     12,023       (6,675 )
    


 


Change in cash and cash equivalents

     (48,697 )     (143,897 )

Cash and cash equivalents at beginning of period

     66,524       244,070  
    


 


Cash and cash equivalents at end of period

   $ 17,827     $ 100,173  
    


 


 

10


KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Operations (a)

(Unaudited)

(In thousands, except per share amounts)

 

     2003 Quarters

          First
Quarter
2004


 
     First

    Second

    Third

    Fourth

    Year

   

Revenues

   $ 802,158     $ 813,848     $ 837,035     $ 830,978     $ 3,284,019     $ 871,262  
    


 


 


 


 


 


Salaries, wages and benefits

     460,752       462,320       469,112       473,263       1,865,447       492,071  

Supplies

     104,182       104,440       107,701       113,293       429,616       116,733  

Rent

     63,078       64,215       64,783       64,230       256,306       64,459  

Other operating expenses

     146,839       140,776       144,368       131,524       563,507       145,406  

Depreciation

     19,195       19,927       20,407       21,328       80,857       22,046  

Interest expense

     2,888       2,992       1,054       3,388       10,322       3,656  

Investment income

     (1,635 )     (1,676 )     (1,333 )     (1,491 )     (6,135 )     (1,218 )
    


 


 


 


 


 


       795,299       792,994       806,092       805,535       3,199,920       843,153  
    


 


 


 


 


 


Income from continuing operations before reorganization items and income taxes

     6,859       20,854       30,943       25,443       84,099       28,109  

Reorganization items

     —         —         —         1,010       1,010       —    
    


 


 


 


 


 


Income from continuing operations before income taxes

     6,859       20,854       30,943       26,453       85,109       28,109  

Provision for income taxes

     4,348       7,710       12,629       10,968       35,655       11,834  
    


 


 


 


 


 


Income from continuing operations

     2,511       13,144       18,314       15,485       49,454       16,275  

Discontinued operations, net of income taxes:

                                                

Loss from operations

     (15,635 )     (20,555 )     (5,780 )     (3,407 )     (45,377 )     (2,435 )

Loss on divestiture of operations

     —         (36,019 )     (827 )     (42,567 )     (79,413 )     —    
    


 


 


 


 


 


Net income (loss)

   $ (13,124 )   $ (43,430 )   $ 11,707     $ (30,489 )   $ (75,336 )   $ 13,840  
    


 


 


 


 


 


Earnings (loss) per common share:

                                                

Basic:

                                                

Income from continuing operations

   $ 0.07     $ 0.38     $ 0.53     $ 0.44     $ 1.42     $ 0.46  

Discontinued operations:

                                                

Loss from operations

     (0.45 )     (0.59 )     (0.17 )     (0.10 )     (1.30 )     (0.07 )

Loss on divestiture of operations

     —         (1.04 )     (0.02 )     (1.21 )     (2.28 )     —    
    


 


 


 


 


 


Net income (loss)

   $ (0.38 )   $ (1.25 )   $ 0.34     $ (0.87 )   $ (2.16 )   $ 0.39  
    


 


 


 


 


 


Diluted:

                                                

Income from continuing operations

   $ 0.07     $ 0.38     $ 0.52     $ 0.38     $ 1.41     $ 0.38  

Discontinued operations:

                                                

Loss from operations

     (0.45 )     (0.59 )     (0.17 )     (0.08 )     (1.29 )     (0.06 )

Loss on divestiture of operations

     —         (1.04 )     (0.02 )     (1.05 )     (2.27 )     —    
    


 


 


 


 


 


Net income (loss)

   $ (0.38 )   $ (1.25 )   $ 0.33     $ (0.75 )   $ (2.15 )   $ 0.32  
    


 


 


 


 


 


Shares used in computing earnings (loss) per common share:

                                                

Basic

     34,755       34,813       34,885       35,062       34,880       35,414  

Diluted

     34,767       34,828       35,143       40,685       35,047       42,721  

 


(a) Share and per share data for all periods presented have been adjusted retroactively to reflect a 2-for-1 stock split to be distributed in May 2004.

 

11


KINDRED HEALTHCARE, INC.

Condensed Business Segment Data

(Unaudited)

(In thousands)

 

     2003 Quarters

          First
Quarter
2004


 
     First

    Second

    Third

    Fourth

    Year

   

Revenues:

                                                

Hospital division

   $ 331,862     $ 338,360     $ 341,368     $ 325,619     $ 1,337,209     $ 348,648  

Health services division (a)

     410,832       416,768       431,978       433,532       1,693,110       444,994  

Rehabilitation division (a)

     8,502       8,795       12,065       14,121       43,483       52,699  

Pharmacy division

     66,126       64,850       67,075       74,382       272,433       79,746  
    


 


 


 


 


 


       817,322       828,773       852,486       847,654       3,346,235       926,087  

Eliminations:

                                                

Pharmacy

     (15,164 )     (14,925 )     (15,451 )     (16,676 )     (62,216 )     (18,136 )

Rehabilitation (a)

     —         —         —         —         —         (36,689 )
    


 


 


 


 


 


       (15,164 )     (14,925 )     (15,451 )     (16,676 )     (62,216 )     (54,825 )
    


 


 


 


 


 


     $ 802,158     $ 813,848     $ 837,035     $ 830,978     $ 3,284,019     $ 871,262  
    


 


 


 


 


 


Income from continuing operations:

                                                

Operating income (loss):

                                                

Hospital division

   $ 70,538     $ 75,455     $ 87,171     $ 73,702     $ 306,866     $ 80,066  

Health services division (a)

     43,424       57,235       54,944       64,436       220,039       49,469  

Rehabilitation division (a)

     (959 )     (750 )     261       (315 )     (1,763 )     8,519  

Pharmacy division

     6,702       6,133       6,150       7,508       26,493       7,609  

Corporate:

                                                

Overhead

     (26,713 )     (28,354 )     (28,670 )     (28,898 )     (112,635 )     (26,834 )

Insurance subsidiary

     (2,607 )     (3,407 )     (4,002 )     (3,535 )     (13,551 )     (1,777 )
    


 


 


 


 


 


       (29,320 )     (31,761 )     (32,672 )     (32,433 )     (126,186 )     (28,611 )
    


 


 


 


 


 


       90,385       106,312       115,854       112,898       425,449       117,052  

Reorganization items

     —         —         —         1,010       1,010       —    
    


 


 


 


 


 


Operating income

     90,385       106,312       115,854       113,908       426,459       117,052  

Rent

     (63,078 )     (64,215 )     (64,783 )     (64,230 )     (256,306 )     (64,459 )

Depreciation

     (19,195 )     (19,927 )     (20,407 )     (21,328 )     (80,857 )     (22,046 )

Interest, net

     (1,253 )     (1,316 )     279       (1,897 )     (4,187 )     (2,438 )
    


 


 


 


 


 


Income from continuing operations before income taxes

     6,859       20,854       30,943       26,453       85,109       28,109  

Provision for income taxes

     4,348       7,710       12,629       10,968       35,655       11,834  
    


 


 


 


 


 


     $ 2,511     $ 13,144     $ 18,314     $ 15,485     $ 49,454     $ 16,275  
    


 


 


 


 


 



(a) Financial data presented for periods prior to January 1, 2004 have not been restated to reflect the new rehabilitation business alignment.

 

12


KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

(In thousands)

 

     2003 Quarters

        First
Quarter
2004


     First

   Second

   Third

   Fourth

   Year

  

Rent:

                                         

Hospital division

   $ 23,284    $ 23,706    $ 23,441    $ 22,753    $ 93,184    $ 22,844

Health services division (a)

     39,031      39,808      40,459      40,530      159,828      40,283

Rehabilitation division (a)

     69      95      123      185      472      611

Pharmacy division

     630      547      698      703      2,578      662

Corporate

     64      59      62      59      244      59
    

  

  

  

  

  

     $ 63,078    $ 64,215    $ 64,783    $ 64,230    $ 256,306    $ 64,459
    

  

  

  

  

  

Depreciation:

                                         

Hospital division

   $ 7,054    $ 7,450    $ 7,684    $ 8,257    $ 30,445    $ 8,464

Health services division (a)

     6,373      6,569      6,688      6,740      26,370      6,893

Rehabilitation division (a)

     16      20      22      25      83      33

Pharmacy division

     517      539      561      560      2,177      530

Corporate

     5,235      5,349      5,452      5,746      21,782      6,126
    

  

  

  

  

  

     $ 19,195    $ 19,927    $ 20,407    $ 21,328    $ 80,857    $ 22,046
    

  

  

  

  

  

Capital expenditures, excluding acquisitions (including discontinued operations):

                                         

Hospital division

   $ 2,822    $ 4,133    $ 5,773    $ 13,388    $ 26,116    $ 5,406

Health services division (a)

     3,222      6,375      9,768      9,804      29,169      8,450

Rehabilitation division (a)

     51      47      35      11      144      47

Pharmacy division

     616      522      815      2,254      4,207      773

Corporate:

                                         

Information systems

     3,207      5,992      4,071      8,223      21,493      2,651

Other

     647      408      361      1,551      2,967      554
    

  

  

  

  

  

     $ 10,565    $ 17,477    $ 20,823    $ 35,231    $ 84,096    $ 17,881
    

  

  

  

  

  


(a) Financial data presented for periods prior to January 1, 2004 have not been restated to reflect the new rehabilitation business alignment.

 

13


KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

 

     2003 Quarters

        First
Quarter
2004


     First

   Second

   Third

   Fourth

   Year

  

Hospital data:

                                         

End of period data:

                                         

Number of hospitals

     63      63      64      66             68

Number of licensed beds

     5,076      5,098      5,129      5,219             5,323

Revenue mix % (a):

                                         

Medicare

     60      59      62      63      61      66

Medicaid

     8      8      7      8      8      7

Private and other

     32      33      31      29      31      27

Admissions:

                                         

Medicare

     6,612      6,346      6,053      6,681      25,692      6,900

Medicaid

     648      604      670      661      2,583      715

Private and other

     1,281      1,322      1,333      1,359      5,295      1,460
    

  

  

  

  

  

       8,541      8,272      8,056      8,701      33,570      9,075
    

  

  

  

  

  

Patient days:

                                         

Medicare

     216,266      214,116      193,069      191,904      815,355      207,052

Medicaid

     31,764      32,470      31,362      29,488      125,084      27,754

Private and other

     56,225      59,339      54,080      52,725      222,369      52,391
    

  

  

  

  

  

       304,255      305,925      278,511      274,117      1,162,808      287,197
    

  

  

  

  

  

Average length of stay:

                                         

Medicare

     32.7      33.7      31.9      28.7      31.7      30.0

Medicaid

     49.0      53.8      46.8      44.6      48.4      38.8

Private and other

     43.9      44.9      40.6      38.8      42.0      35.9

Weighted average

     35.6      37.0      34.6      31.5      34.6      31.6

Revenues per admission (a):

                                         

Medicare

   $ 30,050    $ 31,594    $ 35,157    $ 30,987    $ 31,878    $ 33,321

Medicaid

     40,547      44,766      36,974      37,825      39,910      33,228

Private and other

     83,449      83,830      77,860      68,870      78,395      65,054

Weighted average

     38,855      40,904      42,374      37,423      39,833      38,419

Revenues per patient day (a):

                                         

Medicare

   $ 919    $ 936    $ 1,102    $ 1,079    $ 1,004    $ 1,110

Medicaid

     827      833      790      848      824      856

Private and other

     1,901      1,868      1,919      1,775      1,867      1,813

Weighted average

     1,091      1,106      1,226      1,188      1,150      1,214

Medicare case mix index (discharged patients only)

     N/A      N/A      N/A      1.20      N/A      1.26

Average daily census

     3,381      3,362      3,027      2,980      3,186      3,156

Occupancy %

     69.8      69.0      61.9      59.9      65.1      62.4

(a) Includes income of $14 million in the third quarter of 2003 and $2 million in the first quarter of 2004 related to certain Medicare reimbursement issues.

 

N/A – not available.

 

14


KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

 

     2003 Quarters

        First
Quarter
2004


     First

   Second

   Third

   Fourth

   Year

  

Nursing center data:

                                         

End of period data:

                                         

Number of nursing centers:

                                         

Owned or leased

     248      248      248      248             247

Managed

     7      7      7      7             7
    

  

  

  

         

       255      255      255      255             254
    

  

  

  

         

Number of licensed beds:

                                         

Owned or leased

     32,293      32,124      32,118      32,124             32,009

Managed

     803      803      803      803             803
    

  

  

  

         

       33,096      32,927      32,921      32,927             32,812
    

  

  

  

         

Revenue mix %:

                                         

Medicare

     33      33      32      33      32      36

Medicaid

     48      48      50      48      49      46

Private and other

     19      19      18      19      19      18

Patient days (excludes managed facilities):

                                         

Medicare

     398,646      399,150      394,957      397,254      1,590,007      433,162

Medicaid

     1,699,726      1,707,907      1,757,580      1,737,615      6,902,828      1,675,706

Private and other

     410,378      418,824      422,529      426,890      1,678,621      407,684
    

  

  

  

  

  

       2,508,750      2,525,881      2,575,066      2,561,759      10,171,456      2,516,552
    

  

  

  

  

  

Revenues per patient day:

                                         

Medicare

   $ 338    $ 342    $ 344    $ 364    $ 347    $ 372

Medicaid

     117      118      123      120      119      121

Private and other

     188      189      188      190      189      197

Weighted average

     164      165      168      169      167      177

Average daily census

     27,875      27,757      27,990      27,845      27,867      27,654

Occupancy %

     86.0      85.6      86.8      86.4      86.2      86.0

Rehabilitation data:

                                         

Revenue mix %:

                                         

Company-operated

     N/A      N/A      N/A      N/A      N/A      70

Non-affiliated

     N/A      N/A      N/A      N/A      N/A      30

Pharmacy data:

                                         

Number of customer licensed beds at end of period:

                                         

Company-operated

     29,804      27,566      27,886      28,280             28,188

Non-affiliated

     28,365      28,848      29,507      33,127             35,102
    

  

  

  

         

       58,169      56,414      57,393      61,407             63,290
    

  

  

  

         


N/A – not applicable.

 

15